What Makes Abraxis BioScience Stand Out in Nanotechnology?
One of the key innovations by Abraxis BioScience is the development of Abraxane, a chemotherapeutic agent that uses nanoparticles to enhance drug delivery. Abraxane is an albumin-bound form of paclitaxel, a drug commonly used in chemotherapy. The use of albumin nanoparticles allows for higher concentrations of the drug to be delivered directly to the tumor site, improving efficacy and reducing side effects.
